Last reviewed · How we verify
NCT05172531
Efficacy and Safety Profile of Cisatracurium Besylate for IAH
NA trial testing Cisatracurium Besylate in Intra-abdominal Hypertension in 80 participants. Status unknown.
30 January 2023
Quick facts
| Lead sponsor | Tianjin Nankai Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 29 August 2022 |
| Primary completion | 30 January 2023 |
| Estimated completion | 1 April 2023 |
Drugs / interventions tested
- Cisatracurium Besylate (Cisatracurium Besylate) — full drug profile →
- saline 0.12ml/kg/hr — full drug profile →
Conditions studied
- Intra-abdominal Hypertension — all drugs for Intra-abdominal Hypertension →
Sponsor
Tianjin Nankai Hospital
Who can join
Adults 18 to 90, any sex, with Intra-abdominal Hypertension. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a randomized, double-blinded, controlled design. In this study, Cisatracurium Besylate was selected for treatment in Intra-abdominal hypertension or abdominal compartment syndrome,accompanied with evaluating the effects on the duration of organ failure,length of hospital stay and mortality.To clarify the effect of Cisatracurium Besylate on IAH/ACS is of great significance to the clinical applications.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05172531
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Cisatracurium Besylate
Trials testing the same drug.
- NCT06214169 — Effect of Addition of Cisatracurium to Lidocaine VS Plain Lidocaine · NA · completed
- NCT05624424 — Effect of Rematazolam Besylate, Propofol, and Sevoflurane Perioperative Sedation on Incidence of Emergence Agitation and · Phase 4 · unknown
- NCT05527314 — Effect of Remimazolam vs Sevoflurane Anesthesia on Incidence of Emergence Agitation and Complications in Children Underg · NA · completed
- NCT02509078 — Reevaluation Of Systemic Early Neuromuscular Blockade · Phase 3 · completed
Other recruiting trials for Intra-abdominal Hypertension
Currently open trials in the same condition.
- NCT06697717 — End-expiratory Transpulmonary Pressure-guided vs Electrical Impedance Tomography-guided PEEP Titration Methods in Patien · NA · recruiting
Other Tianjin Nankai Hospital trials
Trials by the same sponsor.
- NCT06045780 — HO-1/CREB3 Modulates Golgi Stress in Patients With Sepsis · recruiting
- NCT06006325 — Electroacupuncture Modulates SPMs Metabolism and Respiratory Symptoms in Patients With Sepsis Complicating ARDS · NA · unknown
- NCT05476029 — Changes of Exosomes and Biomarkers in Plasma and Alveolar Lavage Fluid of Patients With Sepsis Complicated With ARDS · unknown
- NCT05171699 — Effect of Electroacupuncture in Patients With Sepsis Associated Brain Injury · NA · unknown
- NCT04969068 — The Median Effective Dose of Remimazolam for Duodenoscopy Insertion During ERCP With Alfentanil 10µg/kg · Phase 4 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05172531 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tianjin Nankai Hospital
- Last refreshed: 22 July 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05172531.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing